Enanta Pharmaceuticals, Inc. (ENTA) Social Stream
ENANTA PHARMACEUTICALS INC (ENTA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ENTA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $121 | $55 | $89.777 | $12.04 | 645.66% |
| 2021-11-19 | 10 | $121 | $55 | $89.555 | $12.04 | 643.81% |
| 2021-11-22 | 10 | $111 | $55 | $88.444 | $12.04 | 634.58% |
| 2021-11-23 | 10 | $111 | $71 | $89.666 | $12.04 | 644.73% |
| 2022-01-06 | 9 | $116 | $71 | $89.555 | $12.04 | 643.81% |
| 2022-01-13 | 9 | $116 | $71 | $89 | $12.04 | 639.2% |
| 2022-02-02 | 8 | $116 | $71 | $89 | $12.04 | 639.2% |
| 2022-02-08 | 9 | $116 | $72 | $91.25 | $12.04 | 657.89% |
| 2022-02-16 | 8 | $116 | $68 | $88.875 | $12.04 | 638.16% |
| 2022-05-10 | 8 | $116 | $68 | $87 | $12.04 | 622.59% |
| 2022-05-11 | 8 | $116 | $58 | $81.5 | $12.04 | 576.91% |
| 2022-05-19 | 8 | $116 | $44 | $76 | $12.04 | 531.23% |
| 2022-05-20 | 8 | $116 | $44 | $73.222 | $12.04 | 508.16% |
| 2022-06-01 | 8 | $116 | $39 | $69.777 | $12.04 | 479.54% |
| 2022-06-02 | 9 | $116 | $39 | $69.8 | $12.04 | 479.73% |
| 2022-07-21 | 8 | $116 | $44 | $71.777 | $12.04 | 496.15% |
| 2022-08-01 | 8 | $116 | $50 | $73.333 | $12.04 | 509.08% |
| 2022-08-09 | 8 | $116 | $50 | $73.222 | $12.04 | 508.16% |
| 2022-11-09 | 8 | $137 | $50 | $76.222 | $12.04 | 533.07% |
| 2022-11-22 | 8 | $137 | $50 | $74.888 | $12.04 | 521.99% |
| 2022-11-23 | 8 | $137 | $50 | $73.888 | $12.04 | 513.69% |
| 2022-12-09 | 9 | $137 | $50 | $72.1 | $12.04 | 498.84% |
| 2023-01-27 | 9 | $137 | $49 | $72 | $12.04 | 498.01% |
| 2023-02-07 | 9 | $137 | $49 | $72.3 | $12.04 | 500.5% |
| 2023-03-22 | 9 | $137 | $49 | $72.1 | $12.04 | 498.84% |
| 2023-05-09 | 9 | $137 | $37 | $68.9 | $12.04 | 472.26% |
| 2023-05-11 | 9 | $87 | $30 | $52.333 | $12.04 | 334.66% |
| 2023-07-17 | 7 | $65 | $27 | $44.571 | $12.04 | 270.19% |
| 2023-08-08 | 7 | $65 | $18 | $39.857 | $12.04 | 231.04% |
| 2023-08-09 | 7 | $48 | $14 | $28.142 | $12.04 | 133.74% |
| 2023-10-02 | 7 | $48 | $14 | $26.714 | $12.04 | 121.88% |
| 2023-10-20 | 7 | $48 | $14 | $25.142 | $12.04 | 108.82% |
| 2023-11-20 | 7 | $42 | $14 | $22.571 | $12.04 | 87.47% |
| 2023-11-21 | 7 | $30 | $14 | $19.857 | $12.04 | 64.93% |
| 2023-11-22 | 8 | $28 | $12 | $18.714 | $12.04 | 55.43% |
The Trend in the Analyst Price Target
Over the past 19 months, ENTA's average price target has gone down $66.66.
Over the past 43 weeks, ENTA's average upside potential has been 106.75%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 9 | 137 | 49 | 72.000 | 52.02 | 38.41% |
| 2023-02-14 | 9 | 137 | 49 | 72.100 | 49.76 | 44.9% |
| 2023-05-11 | 9 | 65 | 30 | 48.000 | 25.52 | 88.09% |
| 2023-08-08 | 7 | 65 | 18 | 39.857 | 18.52 | 115.21% |
| 2023-11-20 | 7 | 42 | 14 | 22.571 | 8.94 | 152.47% |
ENTA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.71 | 2 | 0 | 4 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
ENTA's average broker recommendation rating worsened by 0.71 over the prior 18 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ENANTA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 4191.52% of them.
- In the context of all US stocks, ENANTA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -3729.11% of them.
- ENANTA PHARMACEUTICALS INC's average analyst price target is higher than 3339.99% of Pharmaceutical Products stocks.
- In terms of how ENANTA PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2623.57% of that group.
In the Pharmaceutical Products industry, MDGL, MGNX, and CYRX are the three stocks most similar to ENANTA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ENTA using the data that counts. Try POWR Ratings for free.